Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019Gregory A. Roth, Michael Pratt, Leslie T. Cooper et al.|Journal of the American College of Cardiology|2020Cited by 11.1k
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Alize J Ferrari, Robert Kaba Alhassan et al.|The Lancet|2024Cited by 4.4k
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Shahzaib Ahmad, Hazim Ababneh et al.|The Lancet|2024Cited by 931
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road aheadHamed Ekhtiari, Primavera A. Spagnolo, Hosna Tavakoli et al.|Neuroscience & Biobehavioral Reviews|2019Cited by 301
Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative studyFabio Caputo, Mauro Bernardi, Giovanni Addolorato et al.|Drug and Alcohol Dependence|2003Cited by 76